MedPath
NMPA Approval

Fluticasone Propionate Nebuliser Suspension

国药准字H20243929

June 4, 2024

Drug Information

丙酸氟替卡松雾化吸入用混悬液

吸入制剂

2ml:0.5mg

化学药品

June 4, 2024

Company Information

Applicant Company

上海市松江区新桥镇卖新公路1633号

Manufacturing Company

上海市松江区新桥镇卖新公路1633号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

丙酸氟替卡松雾化吸入用混悬液 - NMPA 批准文号 | MedPath